Elypta Overview

  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $6.74M
Latest Deal Amount
  • Investors
  • 8

Elypta General Information


Developer of a liquid biopsy platform company designed to prevent cancer mortality through earlier detection and closer monitoring. The company platform is inherently safe and convenient, exceptionally sensitive in studies to date and the low-cost assay technology allows for broad use and score output is also customizable with early results suggesting a correlation with the severity of the disease, enabling physicians to detect early-stage cancer when symptoms are inconclusive.

Contact Information

Formerly Known As
Aurora Life Sciences
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Teknikringen 38
  • 114 28 Stockholm
  • Sweden
+46 08-520 000 00

Elypta Timeline

Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Elypta Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 01-Dec-2019 $6.74M 00.000 Completed Startup
5. Grant 15-Nov-2019 000.00 00.000 Completed Startup
4. Grant 01-Jan-2019 00.000 00.000 Completed Startup
3. Seed Round 11-Dec-2018 00000 00.000 Completed Startup
2. Seed Round 20-May-2018 $920K $920K Completed Startup
1. Grant 01-Jun-2016 $115K Completed Startup

Elypta Executive Team (3)

Name Title Board Seat Contact Info
Karl Bergman Chief Executive Officer
Francesco Gatto Ph.D Co-Founder & Chief Scientific Officer
Jens Nielsen Ph.D Co-Founder & Board Member

Elypta Board Members (5)

Name Representing Role Since
Anders Ekblom Ph.D Self Chairman 000 0000
Jamal El-Mosleh Self Board Member 000 0000
Jens Nielsen Ph.D Elypta Co-Founder & Board Member 000 0000
Jonas Jendi Industrifonden Board Member 000 0000
Pontus Ottosson Self Board Member 000 0000

Elypta Investors (8)

To view Elypta‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Industrifonden Venture Capital Minority 000 0000 000000 0
Nina Capital Venture Capital Minority 000 0000 000000 0
Norrsken VC Venture Capital Minority 000 0000 000000 0
Sciety Venture Capital Minority 000 0000 000000 0
EIT Health Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial